This has been the hardest part of this investment. It's like gym class where the kid who is picked last actually has the most talent but doesn't look the part.

I'll take Gilead
I'll take Novartis
Let me get Regeneron
...Kamada
...Sanofi
...Distributed Bio
...
Alright fine...looks like we got "Cycho-Dine" That's CytoDyn thank you.

And all that would be humorous and victory would taste so sweet in the end but people are dying. And that makes this maddeningly frustrating. I get the fact that statistics and trials are important...I really do. But can't we say there is statistical significance in having so many positive results in a row? I mean having a coin land on heads 15 times in a row has a probability of 0.00341796875. Having the first 15 critical patients in covid turn around...the first 10 patients with stage 4 cancer turn around...etc. must have some significance that they can use to justify getting this in the hands of those who need it NOW. It's like these trials are designed more for drugs that don't always work and we "unfortunately" have to carry that burden.

I know, patience. But these stories you read are heart wrenching and we have to endure it for a couple of more weeks